Date published: 2026-2-5

1-800-457-3801

SCBT Portrait Logo
Seach Input

Cosmc Inhibitors

Cosmc inhibitors are a class of chemical compounds that specifically target and inhibit the function of the chaperone protein known as Core 1 β3-Gal-T-specific molecular chaperone (Cosmc). Cosmc plays a critical role in the biosynthesis of O-glycans, which are complex carbohydrates attached to the oxygen atom of serine or threonine residues on proteins. Specifically, Cosmc is essential for the proper folding and function of the enzyme T-synthase, which is responsible for the addition of galactose to N-acetylgalactosamine (GalNAc) residues during the formation of Core 1 O-glycans. This glycosylation process is vital for the stability and function of many glycoproteins that participate in cellular signaling, adhesion, and immune responses. By inhibiting Cosmc, researchers can disrupt the biosynthesis of O-glycans, allowing them to study the consequences of altered glycosylation on cellular processes.

In research, Cosmc inhibitors serve as powerful tools to investigate the role of O-glycosylation in protein function and cellular biology. By blocking Cosmc activity, scientists can examine how the inhibition of T-synthase and the subsequent disruption of O-glycan synthesis affect the structure and function of glycoproteins. This disruption can lead to significant changes in protein folding, stability, and interactions, thereby impacting various cellular pathways and physiological processes. Furthermore, Cosmc inhibitors allow researchers to explore the broader implications of altered glycosylation, such as changes in cell surface glycoprotein composition, which can affect cell-cell interactions, signaling, and the immune response. Through these studies, the use of Cosmc inhibitors provides valuable insights into the molecular mechanisms governing O-glycosylation, the critical role of Cosmc in this process, and the overall importance of glycosylation in maintaining cellular function and integrity.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Inhibits mTOR pathway, which can influence glycosylation processes where C1GALT1C1 is active.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Inhibits PI3K pathway, potentially affecting cellular processes that may involve C1GALT1C1.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

Inhibits MEK1, affecting MAPK pathway, which may indirectly regulate C1GALT1C1.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

p38 MAPK inhibitor, can indirectly affect C1GALT1C1 by modulating cellular stress responses.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

Inhibits JNK, another kinase involved in stress response, thereby can affect C1GALT1C1.

Dexamethasone

50-02-2sc-29059
sc-29059B
sc-29059A
100 mg
1 g
5 g
$91.00
$139.00
$374.00
36
(1)

Modulates inflammatory responses that might involve pathways affecting C1GALT1C1.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

HDAC inhibitor, affects gene expression levels and can indirectly inhibit C1GALT1C1.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

DNA methyltransferase inhibitor that can alter gene expression, affecting C1GALT1C1.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

PI3K inhibitor that can affect various cellular processes, thereby affecting C1GALT1C1.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$66.00
$325.00
$587.00
$1018.00
28
(1)

Affects cellular differentiation, potentially affecting the processes that involve C1GALT1C1.